-- 米中央軍は水曜日、封鎖開始から最初の48時間で、米海軍部隊の監視網を通過した船舶は一隻もなかったと発表した。 「イランの港に出入りする船舶に対する米国の封鎖開始から最初の48時間で、米軍部隊の監視網を通過した船舶は一隻もなかった」と、中央軍はXの投稿で述べた。 中央軍によると、これまでに9隻の船舶が米軍の指示に従い、イランの港または沿岸地域へ引き返したという。 米海軍部隊は、封鎖措置の遵守を確実にするため、目に見える形で存在感を示している。 「中央軍がイランの港に出入りする船舶に対する米国の封鎖を継続する中、米海軍艦艇はオマーン湾で哨戒活動を行っている」と中央軍は述べている。 司令部は、部隊は引き続き厳戒態勢を敷き、イランの港に出入りしようとする船舶に対する規制を執行する準備を整えていると発表した。エイブラハム・リンカーン空母打撃群に所属する約5,000人の海軍兵士と海兵隊員が、米国が課した海上封鎖の執行にあたっている。 この封鎖は、米イラン交渉の決裂後、ドナルド・トランプ大統領が4月12日にTruth Socialで発表した指令に基づくもので、同地域における海上規制を強化する内容となっている。 トランプ大統領は投稿の中で、「即日発効で、米海軍はホルムズ海峡に出入りしようとするあらゆる船舶の封鎖を開始する」と述べた。 この封鎖は、イランの主要な収入源である石油輸出を制限することで、イランの経済状況に圧力をかけ、財政基盤を弱体化させることを目的としている。 紛争が7週目に突入する中、ブレント原油は約95.61ドル/バレル、ウエスト・テキサス・インターミディエイト(WTI)は約91.82ドルで取引されており、供給制約が依然として続いていることが浮き彫りになった。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.